Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients

ClinicalTrials.gov ID: NCT00377949

Public ClinicalTrials.gov record NCT00377949. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 7:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the timeline of progression from pre-pulmonary hypertension to diagnosable pulmonary hypertension based on right heart catheterization. Moreover, to determine the timeline for progression from diagnosable pulmonary hypertension to clinical worsening of disease as defined as death, hospitalization, or worsening of PHT symptoms.

Study identification

NCT ID
NCT00377949
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Georgetown University
Other
Enrollment
602 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2005 (Type not available)
Primary completion
Jan 2016 (Actual)
Completion
Not listed
Last update posted
May 3, 2016

Started 2005

United States locations

U.S. sites
25
U.S. states
16
U.S. cities
21
Facility City State ZIP Site status
UCLA Medical Center Los Angeles California 90095 —
Stanford University Stanford California 94305 —
National Jewish Medical and Research Center Denver Colorado 80206 —
Georgetown University Medical Center Washington D.C. District of Columbia 20007 —
Northwestern University Chicago Illinois 60611 —
University of Chicago Chicago Illinois 60637 —
Louisiana State University Health Science Center New Orleans Louisiana 70112 —
John Hopkins University Medical Center Baltimore Maryland 21224 —
Tufts Medical Center Boston Massachusetts 02111 —
Boston University Medical School Boston Massachusetts 02118 —
University of Massachussetts Memorial Medical Center Worcester Massachusetts 01605 —
University of Michigan-Scleroderma Program Ann Arbor Michigan 48109 —
Hennepin County Medical Center Minneapolis Minnesota 55415 —
University of Minnesota Minneapolis Minnesota 55455 —
University of Medicine and Dentistry of New Jersey New Brunswick New Jersey 08903 —
Center for Rheumatology Albany New York 12206 —
North Shore Long Island Jewish Medical Center New Hyde Park New York 11040 —
Hospital for Special Surgery New York New York 10021 —
Cornell University New York New York 10065 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
University of Pittsburgh Pittsburgh Pennsylvania 15261 —
Medical University of South Carolina Charleston South Carolina 29425 —
The University of Texas Health Science Center Houston Texas 77030 —
University of Utah Salt Lake City Utah 84132 —
The Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00377949, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 3, 2016 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00377949 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →